In-vivo Efficacy Study of Patient Preoperative Preps

Stopped early · Phase 3

Conditions studied: Skin Flora Bacterial Reduction Post-product Application

In brief

The purpose of this study is to evaluate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Key facts

Study ID

NCT01968356

Run by

Solventum US LLC

People needed

171

Starts

2013-10-01

Expected to finish

2014-01-01

Last updated by the study team

2024-10-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects of any race
• Subjects in good general health
• Minimum skin flora baseline requirements on abdomen and groin

You may not qualify if…

• Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin disorders (including acne) on the applicable test areas
• Topical antimicrobial exposure within 14 days prior to screening and treatment days
• Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days

Where it is running

• BioScience Laboratories, Inc. — Bozeman, Montana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.